Tags: Drug.
Nabiximols (USAN trade name Sativex) is a patented cannabinoid oromucosal mouth spray developed by the UK company GW Pharmaceuticals for multiple sclerosis (MS) patients who can use it to alleviate neuropathic pain spasticity overactive bladder and other symptoms. Nabiximols is distinct from all other pharmaceutically produced cannabinoids currently available because it is a mixture of compounds derived from Cannabis plants rather than a mono-molecular synthetic product.
